ANI 製藥公司
DE ˙ DB ˙ US00182C1036
€54.50 0.00 (0.00%)
2023-08-21
分享價格
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership184,852 shares
Latest Disclosed Value $ 14,215,120
Northern Trust Corp reports 4.55% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 184,852 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $14,215,120 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 176,814 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 4.55% during the quarter. The current value of the position is $10,074,434 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 184,852 8,038 4.55 14,215 1.85 0.0004
2026-02-17 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 176,814 -11,785 -6.25 13,958 -19.21 0.0004
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 188,599 -874 -0.46 17,276 39.73 0.0005
2025-08-13 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 189,473 -27,389 -12.63 12,363 -14.84 0.0017
2025-05-13 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 216,862 12,517 6.13 14,519 28.52 0.0022
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 204,345 16,820 8.97 11,296 0.97 0.0016
2024-11-13 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 187,525 19,780 11.79 11,188 4.73 0.0018
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 167,745 4,399 2.69 10,682 -5.40 0.0018
2024-05-14 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 163,346 -3,756 -2.25 11,292 22.55 0.0020
2024-02-13 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 167,102 -3,083 -1.81 9,214 -6.74 0.0017
2023-11-13 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 170,185 15,633 10.12 9,881 18.76 0.0019
2023-08-11 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 154,552 14,710 10.52 8,320 49.78 0.0016
2023-05-15 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 139,842 -1,672 -1.18 5,555 -2.44 0.0011
2023-02-13 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 141,514 4,735 3.46 5,693 29.50 0.0012
2022-11-14 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 136,779 845 0.62 4,396 9.03 0.0010
2022-08-12 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 135,934 11,333 9.10 4,032 15.10 0.0009
2022-05-13 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 124,601 -1,158 -0.92 3,503 -39.55 0.0006
2022-02-08 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 125,759 7,374 6.23 5,795 49.16 0.0009
2021-11-15 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 118,385 -196 -0.17 3,885 -6.52 0.0007
2021-08-13 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 118,581 1,528 1.31 4,156 -1.75 0.0007
2021-05-12 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 117,053 -7,639 -6.13 4,230 16.82 0.0008
2021-02-11 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 124,692 960 0.78 3,621 3.75 0.0007
2020-11-16 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 123,732 -4,371 -3.41 3,490 -15.78 0.0008
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 128,103 -3,294 -2.51 4,144 -22.59 0.0010
2020-05-14 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 131,397 2,790 2.17 5,353 -32.51 0.0015
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 128,607 -4,510 -3.39 7,931 -18.25 0.0018
2019-11-13 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 133,117 14,076 11.82 9,701 -0.86 0.0023
2019-08-13 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 119,041 2,404 2.06 9,785 18.94 0.0023
2019-05-13 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 116,637 -526 -0.45 8,227 55.99 0.0020
2019-02-12 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 117,163 -928 -0.79 5,274 -21.00 0.0015
2018-11-14 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 118,091 1,285 1.10 6,676 -14.44 0.0016
2018-09-18 2018-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 116,806 4,710 4.20 7,803 19.57 0.0020
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 117,516 5,420 7,850
2018-05-09 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 112,096 -1,505 -1.32 6,526 -10.86 0.0017
2018-02-14 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 113,601 -43 -0.04 7,321 22.73 0.0019
2017-11-13 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 113,644 739 0.65 5,965 12.87 0.0016
2017-08-11 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 112,905 5,599 5.22 5,285 -0.51 0.0015
2017-05-12 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 107,306 4,141 4.01 5,312 -15.06 0.0015
2017-02-13 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 103,165 1,884 1.86 6,254 -6.95 0.0019
2016-11-09 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 101,281 1,681 1.69 6,721 20.88 0.0021
2016-08-12 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 99,600 451 0.45 5,560 66.57 0.0018
2016-08-19 2016-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 99,149 924 0.94 3,338 -24.68 0.0011
2016-05-13 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 99,149 3,338
2016-02-12 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 98,225 7,206 7.92 4,432 23.25 0.0015
2015-11-12 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 91,019 10,644 13.24 3,596 -27.89 0.0012
2015-08-13 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 80,375 5,140 6.83 4,987 5.97 0.0034
2015-05-14 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 75,235 1,911 2.61 4,706 13.81 0.0014
2015-02-12 2014-12-31 13F ANI PHARMACEUTICALS COM 00182C103 73,324 -1,564 -2.09 4,135 95.23 0.0012
2014-11-13 2014-09-30 13F ANI PHARMACEUTICALS COM 00182C103 74,888 56,738 312.61 2,118 238.88 0.0007
2014-08-14 2014-06-30 13F ANI PHARMACEUTICALS COM 00182C103 18,150 7,334 67.81 625 84.37 0.0002
2014-05-14 2014-03-31 13F ANI PHARMACEUTICALS COM 00182C103 10,816 749 7.44 339 67.82 0.0001
2014-02-21 2013-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 10,067 10,067 202 0.0001
2014-02-12 2013-12-31 13F ANI PHARMACEUTICALS COM 00182C103 10,067 202 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.